bioRxiv ScienceSearch

bioRxiv · 10.1101/2021.04.20.440661

ACUTE FOOD DEPRIVATION DECREASES THE EXPRESSION OF METHAMPHETAMINE-INDUCED LOCOMOTOR SENSITIZATION IN RATS

Abstract

INTRODUCTIONAMPH and METH are known to increase DAergic signaling in the brain reward system by stimulating the release of DA through the reversal of DAT function. However, there is evidence that insulin signaling pathways have the ability to modulate DAT functions. Some studies have reported that hypoinsulinemia attenuates DAT functions, and as a consequence, psychostimulant-induced behaviors are reduced. In the present study, we examined the effects of acute food deprivation, which also reduces insulin levels, on METH-induced locomotor sensitization. METHODSSeparate groups of rats were treated with METH (1 mg/kg i.p.) or saline for 5 days (development phase). On the test day (expression phase), the groups were treated with METH or saline after food deprivation for 24 h. Furthermore, in separate groups of rats, levels of glucose, insulin, and phosphorylation of Akt at Ser473 were also examined after food deprivation for 24 h. RESULTSThe results showed that repeated administration of METH induced a progressive increase in locomotor activity in rats during the development phase. However, METH administration in the expression phase produced a decrease in locomotor activity after 24 h of food deprivation. In addition, the results showed that a reduction in glucose, insulin, and Akt levels occurred as a result of food deprivation. CONCLUSIONThese results are in line with previous studies and suggest that food deprivation reduces some behavioral effects of psychostimulants such as AMPH and METH. HighlightsAdministration of METH increases DAergic neurotransmission by interfering with proper DA transporter (DAT) function Some evidence suggests that insulin signaling pathways modulate the DAT in the brain reward system Acute food deprivation reduces glucose and insulin levels This study examined the effects of acute food deprivation on METH-induced locomotor sensitization Present study showed that food deprivation for 24 h reduced METH-induced locomotor sensitization Plain Language SummaryThe dopamine transporter (DAT) is responsible for the reuptake of dopamine (DA) and the termination of DA neurotransmission. DAT is also the target for psychostimulant drugs such as cocaine, amphetamine, and methamphetamine. These drugs produce an increase of DA neurotransmission in the reward system. It is now well established that insulin levels modulate DAT function. Several studies have reported that hypoinsulinemia attenuates DAT function, and as a consequence, psychostimulant-induced behaviors are reduced. Food deprivation reduces glucose and insulin levels. In the present study we evaluated the effects of food deprivation on methamphetamine-induced locomotor sensitization. This behavior reflects brain neuroadaptations that contribute to drug addiction. Rats of the main experimental group were treated with methamphetamine for 5 days (development phase). On the test day (expression phase) the rats were treated with methamphetamine after food deprivation for 24 h. In separated groups of rats levels of glucose and insulin were evaluated after food deprivation for 24 h. The results showed that acute food deprivation reduced methamphetamine-induced locomotor sensitization. It was also observed that insulin and glucose levels were reduced after food deprivation. The results of the present study suggest that food deprivation can modulate some behavioral effects of methamphetamine.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jimenez, J. C., Miranda-Barrientos, J., Becerra-Diaz, M., Miranda, F.. 2021-04-20. ACUTE FOOD DEPRIVATION DECREASES THE EXPRESSION OF METHAMPHETAMINE-INDUCED LOCOMOTOR SENSITIZATION IN RATS. https://doi.org/10.1101/2021.04.20.440661

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience